BACK TO TOP
KSE100
181,398.21
887.19
(0.49%)
KSE100PR
55,315.72
270.54
(0.49%)
ALLSHR
109,207.08
651.21
(0.60%)
KSE30
54,098.49
257.23
(0.48%)
KMI30
258,982.78
1632.68
(0.63%)
BKTI
49,433.59
-23.01
(-0.05%)
OGTI
37,143.87
217.29
(0.59%)
KMIALLSHR
70,885.99
471.82
(0.67%)
PSXDIV20
83,730.08
251.58
(0.30%)
UPP9
63,889.92
432.60
(0.68%)
NITPGI
47,939.02
247.77
(0.52%)
NBPPGI
52,128.00
318.87
(0.62%)
MZNPI
31,829.04
274.85
(0.87%)
JSMFI
43,424.72
373.49
(0.87%)
ACI
24,308.24
23.18
(0.10%)
JSGBKTI
75,250.57
-53.35
(-0.07%)
HBLTTI
18,570.72
17-06-2026
7.97
(0.04%)
MII30
23,613.79
198.60
(0.85%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.410.00
0.73
(0.18%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Jun 18, 2026 3:45 PM
REG
DFC
CSF
ODL
Open
408.99
High
411.00
Low
401.25
Volume
22,218
CIRCUIT BREAKER
368.34 — 450.20
DAY RANGE
401.25 — 411.00
52-WEEK RANGE ^
293.01 — 475.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
409.27
VAR
19.50
HAIRCUT
22.50
P/E Ratio (TTM) **
27.78
1-Year Change * ^
11.40%
YTD Change * ^
9.12%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
17,822,310.91
Shares
43,469,051
Free Float
15,214,168
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31-03-2026 View   PDF
Apr 29, 2026Financial Results for the Quarter Ended 31-03-2026 View   PDF
Feb 27, 2026Transmission of Quarterly Financial Statements for the Period Ended 31-12-2025 View   PDF
Feb 26, 2026Financial Results for the Quarter Ended 31-12-2025 View   PDF
Oct 30, 2025Transmission of Quarterly Financial Statements for the Period Ended 30-09-2025 View   PDF
DateTitleDocument
Jun 12, 2026Notice of Extraordinary General Meeting View   PDF
Jun 11, 2026Notice of Extraordinary General Meeting prior to publication View   PDF
Apr 22, 2026Board Meeting View   
Feb 19, 2026Board Meeting View   
Oct 27, 2025Certified True Copies of the Resolutions passed in the 69th Annual General Meeting of the Company View   PDF
DateTitleDocument
Jun 2, 2026Intimation of Passing Away of Mrs. Akhter Khalid Waheed, Chairperson and Director View   PDF
Dec 19, 2025Change of Chief Financial Officer View   
Nov 20, 2025Corporate Briefing Session - Presentation View   PDF
Nov 18, 2025Corporate Briefing Session View   PDF
Nov 5, 2025Credit of Final Cash Dividend View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,857,96712,711,7149,893,3917,806,414
Profit after Taxation528,243400,054189,042514,149
EPS12.159.204.3511.83
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,659,6864,405,7813,883,2523,778,689
Profit after Taxation150,250171,195182,420138,117
EPS3.463.934.203.18
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)41.2738.8838.6345.06
Net Profit Margin (%)3.813.151.916.59
EPS Growth (%)32.07111.49(63.23)(40.91)
PEG1.000.24(0.50)(0.56)

Payouts

Financial Reports